Jan Noukens

Pharmacokinetic Drug Interaction Studies with Enzalutamide

Jacqueline A. Gibbons, Michiel S. de Vries, Walter Krauwinkel et al. · Clinical Pharmacokinetics · 2015 · 158 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES

Dirk Roymans, Pieter Annaert, Jos Van Houdt et al. · Drug Metabolism and Disposition · 2005 · 78 citations

Life Sciences, Biochemistry, Pharmacology +15

Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+)

James F. Howard, Tuan Vu, George Li et al. · Neurotherapeutics · 2024 · 47 citations · Full text

Medicine, Endocrinology, Internal Medicine +6

Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Dorien Groenendaal‐van de Meent, Martin den Adel, Jan Noukens et al. · Clinical Drug Investigation · 2016 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A comparison of the pharmacokinetics and safety of enzalutamide in subjects with hepatic impairment and matched healthy subjects

Walter Krauwinkel, Jan Noukens, Jan van Dijk et al. · Journal of Clinical Pharmacy and Therapeutics · 2017 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15